NCT04277572 (Aortic Surgery) is a clinical trial of Aortic valve replacement in Aortic Valve Disease, sponsored by Assiut University.

Who is sponsoring NCT04277572?

NCT04277572 is sponsored by Assiut University.

What drugs are being tested in NCT04277572?

Interventions in NCT04277572: Aortic valve replacement.

What condition does NCT04277572 study?

NCT04277572 studies Aortic Valve Disease.

Is NCT04277572 still recruiting?

NCT04277572 is currently status unknown. Last updated 20 February 2020.

Last reviewed 2020-02-20 · How we verify

NCT04277572: Aortic Surgery

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcomes of Surgery of Aortic Valve

Status unknown Last updated 20 February 2020

What this trial tests

trial testing Aortic valve replacement in Aortic Valve Disease in 30 participants. Status unknown.

Timeline

1 March 2020

Primary endpoint
28 February 2022

31 December 2022

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 March 2020
Primary completion	28 February 2022
Estimated completion	31 December 2022

Drugs / interventions tested

Aortic valve replacement

Conditions studied

Aortic Valve Disease — all drugs for Aortic Valve Disease →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Aortic Valve Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Overall Goal: To study the outcomes of patients undergoing aortic valve surgeries, different approaches such as standard aortic valve replacement, aortic valve repair, novel techniques as Ozaki's procedure and their subsequent results and complications. * Objective 1: Identify predictors of complications following different types of aortic valve surgery accordingly. * Objective 2: Determine the value of each type in terms of advantages and disadvantages. * Objective3: Assess outcomes such as postoperative life expectancy, hospital stay, prognosis and quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Aortic valve replacement

Trials testing the same drug.

NCT06964035 — Influence of Original Native Aortic Valve Lesion (Stenosis or Steno-insufficiency vs. Insufficiency) on Post-implant Str · enrolling by invitation
NCT05774808 — Fate of Moderate Secondary Mitral Regurgitation in Patients Undergoing Aortic Valve Surgery for Severe Aortic Regurgitat · completed
NCT05404100 — Effects of Aortic Valve Replacement on Myocardial T1 Values in Severe Aortic Valve Stenosis · completed
NCT04455165 — Factors Influencing Morbi-mortality in Right Anterior Minithoracotomy Approch for Aortic Valve Replacement · completed
NCT04204915 — The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study · NA · recruiting

Other recruiting trials for Aortic Valve Disease

Currently open trials in the same condition.

NCT07008911 — CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation · NA · recruiting
NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting
NCT07021612 — A Clinical and Imaging Registry of Transcatheter Aortic Valve Implantation Using JenaValve System/ J-Valve System for Pa · recruiting
NCT06896227 — TAVR: The Impact of Prothesis Positioning on Valvular and Coronary Hemodynamics · NA · recruiting
NCT06189976 — Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04277572 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 20 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04277572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing